joi to the universe
ePortfolio
From Animal Models to New Approach Methodologies
Biomedical research has relied heavily on animal models as important tools for studying how the human body works, how diseases develop, and how new treatments are created. Throughout history, animals such as mice, rats, and various primates have been used to help scientists examine biological processes that cannot be safely or ethically tested directly in humans. These animal models allow researchers to observe biological systems within a living organism, which has made them a major part of many medical discoveries over time. Processes such as immune responses, brain signaling, and communication between organs are often easier to understand when studied within a complete living system. By using animal models, researchers can observe how these systems interact with one another, which helps scientists better understand how diseases develop and progress in ways that relate to human biology.
The Role and Utility of Animal Models
Animal models have historically served as a critical bridge between laboratory discovery and human application. Their primary value lies in the ability to observe biological systems within a complete, living organism, offering insights into disease development that relate to human biology. For instance, genetically modified mice have been indispensable in oncology and immunology, allowing researchers to alter specific genes and observe the subsequent effects on the entire body.
Furthermore, animal studies function as a necessary middle step in preclinical testing. Before a new treatment reaches human participants, these models help determine safety, dosage, and potential side effects, thereby reducing risk. Many of modern medicine's greatest achievements, including vaccines and antibiotics, relied on animal testing during their early development phases. Without these models, researchers would face significant ethical hurdles and uncertainty, which could potentially stall medical progress.
Strengths and Historical Contributions
Despite their historical importance, animal models possess inherent limitations that have sparked recent debate. A growing body of evidence suggests that results from animal studies do not always translate accurately to human patients. Biological and environmental differences mean that animals and humans often respond differently to the same diseases or treatments. Consequently, many treatments that appear successful in animal trials fail during human testing, highlighting a gap in the predictive power of these models. These challenges have prompted federal agencies, such as the U.S. Food and Drug Administration (FDA), to explore regulations that reduce dependence on animal testing in favor of more reliable methods
Limitations and the Need for Change
However, recent debates about new regulations, including efforts by the U.S. Food and Drug Administration (FDA) to reduce dependence on animal testing, have raised questions about whether animal models are still the best approach today. Growing scientific evidence shows that results from animal studies do not always translate well to humans. Animals and humans can respond differently to disease and treatment because of biological and environmental differences, which may make some findings less reliable when applied to people. Even when treatments appear effective in animals, they sometimes fail during later human testing, highlighting limits in how accurately animal models can predict human responses.
The Emergence of New Approach Methodologies (NAMs)
New approach methodologies (NAMs), such as organ-on-a-chip systems, organoids, and computational models, are becoming more useful as alternatives. According to the Nature article, governments and federal agencies are actively working toward reducing animal testing, aiming to make animal studies "the exception rather than the norm". One of the main advantages of organs-on-chips and 3D organoids is that they use human-derived stem cells, specifically induced pluripotent stem cells (iPSCs), which allows them to more closely mimic human biology. Because these models are based on human biology rather than animal systems, they can better replicate how human tissue responds to drugs. For example, a study analyzing 870 human liver chips found that they were able to accurately identify harmful drug effects and may help save billions of dollars in drug development costs.
In addition to physical models, Computer and AI models are also becoming important tools. These models use large datasets from previous human and laboratory studies to predict how drugs will behave in the body, and some can even simulate experimental results.
Future Outlook and Challenges
Despite these advantages, there are still important limitations to these alternative methods. Many of these models simplify biological systems and do not fully capture the complexity of a whole organism. For example, organ-on-a-chip systems may only include an isolated number of cell types, while real human organs involve many interacting systems. Certain aspects of human biology, such as interactions between organ systems and long-term changes in the body, are still hard to recreate without animal models.
Before these alternative methods can replace animal models, researchers have to prove that they are reliable and produce consistent results. This process of validation is a main challenge, as regulators need to be confident that these methods actually work before they can approve them. Overall, there is a clear shift toward NAMs because they are more relevant to human biology and raise fewer ethical concerns. However, since these methods haven't developed enough yet to completely replace animal models in all situations, research will probably continue using a mix of both approaches for now.